Advancing therapy for neuroblastoma
B Qiu, KK Matthay - Nature Reviews Clinical Oncology, 2022 - nature.com
Neuroblastomas are tumours of sympathetic origin, with a heterogeneous clinical course
ranging from localized or spontaneously regressing to widely metastatic disease …
ranging from localized or spontaneously regressing to widely metastatic disease …
Neuroblastoma heterogeneity, plasticity, and emerging therapies
KI Lundberg, D Treis, JI Johnsen - Current Oncology Reports, 2022 - Springer
Abstract Purpose of Review The evolving information of the initiation, tumor cell
heterogeneity, and plasticity of childhood neuroblastoma has opened up new perspectives …
heterogeneity, and plasticity of childhood neuroblastoma has opened up new perspectives …
Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma
K Helmsauer, ME Valieva, S Ali… - Nature …, 2020 - nature.com
MYCN amplification drives one in six cases of neuroblastoma. The supernumerary gene
copies are commonly found on highly rearranged, extrachromosomal circular DNA (ecDNA) …
copies are commonly found on highly rearranged, extrachromosomal circular DNA (ecDNA) …
Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma
Noradrenergic and mesenchymal identities have been characterized in neuroblastoma cell
lines according to their epigenetic landscapes and core regulatory circuitries. However, their …
lines according to their epigenetic landscapes and core regulatory circuitries. However, their …
IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression
Background Neuroblastoma is the most common solid tumor in infants accounting for
approximately 15% of all cancer-related deaths. Over 50% of high-risk neuroblastoma …
approximately 15% of all cancer-related deaths. Over 50% of high-risk neuroblastoma …
Neuroblastoma and the epigenome
IS Fetahu, S Taschner-Mandl - Cancer and Metastasis Reviews, 2021 - Springer
Neuroblastoma (NB) is a pediatric cancer of the sympathetic nervous system and one of the
most common solid tumors in infancy. Amplification of MYCN, copy number alterations …
most common solid tumors in infancy. Amplification of MYCN, copy number alterations …
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
B Decaesteker, A Louwagie, S Loontiens… - Nature …, 2023 - nature.com
The pediatric extra-cranial tumor neuroblastoma displays a low mutational burden while
recurrent copy number alterations are present in most high-risk cases. Here, we identify …
recurrent copy number alterations are present in most high-risk cases. Here, we identify …
Targeting KDM4 for treating PAX3-FOXO1–driven alveolar rhabdomyosarcoma
Chimeric transcription factors drive lineage-specific oncogenesis but are notoriously difficult
to target. Alveolar rhabdomyosarcoma (RMS) is an aggressive childhood soft tissue …
to target. Alveolar rhabdomyosarcoma (RMS) is an aggressive childhood soft tissue …
ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression
Mutations in genes encoding SWI/SNF chromatin remodeling complexes are found in
approximately 20% of all human cancers, with ARID1A being the most frequently mutated …
approximately 20% of all human cancers, with ARID1A being the most frequently mutated …
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
Z Nagy, JA Seneviratne, M Kanikevich… - Nature …, 2021 - nature.com
To achieve the very high oncoprotein levels required to drive the malignant state cancer
cells utilise the ubiquitin proteasome system to upregulate transcription factor levels. Here …
cells utilise the ubiquitin proteasome system to upregulate transcription factor levels. Here …